相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microbial enzymes for deprivation of amino acid metabolism in malignant cells: biological strategy for cancer treatment
Rakhi Dhankhar et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
Bifunctional RNA-Targeting Deoxyribozyme Nanodevice as a Potential Theranostic Agent
Aleksandr A. Spelkov et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas
Chie Nakashima et al.
Oncotarget (2020)
Engineering commensal bacteria to rewire host-microbiome interactions
In Young Hwang et al.
CURRENT OPINION IN BIOTECHNOLOGY (2020)
Use of a genetically engineered E. coli overexpressing β-glucuronidase accompanied by glycyrrhizic acid, a natural and anti-inflammatory agent, for directed treatment of colon carcinoma in a mouse model
Amin Afkhami-Poostchi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Daniel S. Leventhal et al.
NATURE COMMUNICATIONS (2020)
Talkin’ Toxins: From Coley’s to Modern Cancer Immunotherapy
Robert D. Carlson et al.
Toxins (2020)
Obligate and facultative anaerobic bacteria in targeted cancer therapy: Current strategies and clinical applications
Mateusz Drozdz et al.
LIFE SCIENCES (2020)
Anti-tumor effect of a recombinant Bifidobacterium strain secreting a claudin-targeting molecule in a mouse breast cancer model
Yoshimi Shimizu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Imaging of tumor colonization by Escherichia coli using 18F-FDS PET
Sae-Ryung Kang et al.
THERANOSTICS (2020)
Nanoliposomal L-Asparaginase and Its Antitumor Activities in Lewis Lung Carcinoma Tumor-Induced BALB/c Mice
Thi Thao Do et al.
ADVANCES IN MATERIALS SCIENCE AND ENGINEERING (2019)
The promise of Immuno-oncology: implications for defining the value of cancer treatment
Howard L. Kaufman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Fas-associated factor 1 mediates NADPH oxidase-induced reactive oxygen species production and proinflammatory responses in macrophages against Listeria infection
Tae-Hwan Kim et al.
PLOS PATHOGENS (2019)
Bacteriotherapy in Breast Cancer
Atieh Yaghoubi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Bacteria-cancer interactions: bacteria-based cancer therapy
Mai Thi-Quynh Duong et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Pseudomonas Exotoxin Immunotoxins and Anti-Tumor Immunity: From Observations at the Patient's Bedside to Evaluation in Preclinical Models
Yasmin Leshem et al.
TOXINS (2019)
Gut Microbiota and Cancer: From Pathogenesis to Therapy
Silvia Vivarelli et al.
CANCERS (2019)
Listeria monocytogenes Cancer Vaccines: Bridging Innate and Adaptive Immunity
Zachary T. Morrow et al.
CURRENT CLINICAL MICROBIOLOGY REPORTS (2019)
Oncolytic Bacteria and their potential role in bacterium-mediated tumour therapy: a conceptual analysis
Yuqing Wang et al.
JOURNAL OF CANCER (2019)
Clostridium difficile toxin B recombinant protein inhibits tumor growth and induces apoptosis through inhibiting Bcl-2 expression, triggering inflammatory responses and activating C-erbB-2 and Cox-2 expression in breast cancer mouse model
Yunli Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Genetically-engineered Salmonella typhimurium expressing TIMP-2 as a therapeutic intervention in an orthotopic glioma mouse model
Min Wen et al.
CANCER LETTERS (2018)
Engineering bacteria for diagnostic and therapeutic applications
David T. Riglar et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Bio-inspired drug delivery systems: an emerging platform for targeted cancer therapy
Gella Maelys Ngandeu Neubi et al.
BIOMATERIALS SCIENCE (2018)
A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer
Friedrich H. Schmitz-Winnenthal et al.
ONCOIMMUNOLOGY (2018)
Anticancer Activity of Bacterial Proteins and Peptides
Tomasz M. Karpinski et al.
PHARMACEUTICS (2018)
Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention
Chun Loong Ho et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma
Kei Kawaguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Recombinant Listeria promotes tumor rejection by CD8+ T cell-dependent remodeling of the tumor microenvironment
Weiwen Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Tumour-targeting bacteria engineered to fight cancer
Shibin Zhou et al.
NATURE REVIEWS CANCER (2018)
Growth inhibitory and proapoptotic effects of l-asparaginase from Fusarium culmorum ASP-87 on human leukemia cells (Jurkat)
Anil K. Meghavarnam et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2017)
Bifidobacterium breve as a delivery vector of IL-24 gene therapy for head and neck squamous cell carcinoma in vivo
L. Wang et al.
GENE THERAPY (2017)
Bleomycin analogues preferentially cleave at the transcription start sites of actively transcribed genes in human cells
Jon K. Chen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin
Jin Hai Zheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Modulation of Salmonella Tumor-Colonization and Intratumoral Anti-angiogenesis by Triptolide and Its Mechanism
Jianxiang Chen et al.
THERANOSTICS (2017)
Probiotic strain Lactobacillus casei BL23 Prevents colitis-associated colorectal cancer
Elsa Jacouton et al.
FRONTIERS IN IMMUNOLOGY (2017)
Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy
Min Gao et al.
CHEMICAL SOCIETY REVIEWS (2017)
Bacteria and genetically modified bacteria as cancer therapeutics: Current advances and challenges
Shreeram C. Nallar et al.
CYTOKINE (2017)
Lactobacillus plantarum induces apoptosis in oral cancer KB cells through upregulation of PTEN and downregulation of MAPK signaling pathways
Abbas Asoudeh-Fard et al.
BIOIMPACTS (2017)
Radiotherapy combined with an engineered Salmonella typhimurium inhibits tumor growth in a mouse model of colon cancer
Xiande Liu et al.
EXPERIMENTAL ANIMALS (2016)
Synchronized cycles of bacterial lysis for in vivo delivery
M. Omar Din et al.
NATURE (2016)
Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions
Ouajdi Felfoul et al.
NATURE NANOTECHNOLOGY (2016)
Blockage of autophagy pathway enhances Salmonella tumor-targeting
Binghong Liu et al.
ONCOTARGET (2016)
Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo
Tomas Fiedler et al.
CANCER BIOLOGY & THERAPY (2015)
Tumor-targeting Salmonella typhimurium A1-R arrests growth of breast-cancer brain metastasis
Yong Zhang et al.
ONCOTARGET (2015)
The mechanism of action of BCG therapy for bladder cancer-a current perspective
Gil Redelman-Sidi et al.
NATURE REVIEWS UROLOGY (2014)
Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8
Masahide Shinnoh et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Lactobacillus plantarum AS1 Isolated from South Indian Fermented Food Kallappam Suppress 1,2-Dimethyl Hydrazine (DMH)-Induced Colorectal Cancer in Male Wistar Rats
R. Satish Kumar et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2012)
Motility is critical for effective distribution and accumulation of bacteria in tumor tissue
Bhushan J. Toley et al.
INTEGRATIVE BIOLOGY (2012)
Clinical Development of Listeria monocytogenes-Based Immunotherapies
Dung T. Le et al.
SEMINARS IN ONCOLOGY (2012)
Bacteria in cancer therapy: a novel experimental strategy
S. Patyar et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Pharmacologic and toxicologic evaluation of C-novyi-NT spores
LA Diaz et al.
TOXICOLOGICAL SCIENCES (2005)
Pilot trial of genetically modified, attenuated Salmonella expressing the E-coli cytosine deaminase gene in refractory cancer patients
J Nemunaitis et al.
CANCER GENE THERAPY (2003)
Continuous intravenous administration of live genetically modified Salmonella typhimurium in patients with metastatic melanoma
DM Heimann et al.
JOURNAL OF IMMUNOTHERAPY (2003)
分享论文
